7:05 am QLT Inc announces positive preliminary results from Phase 1b retreatment trial of QLT091001 in subjects with Leber Congenital Amaurosis and Retinitis Pigmentosa due to mutations in LRAT or RPE65; preliminary results showed clinicall
View todays social media effects on QLTI
View the latest stocks trending across Twitter. Click to view dashboard
See who QLT is hiring next, click here to view
